𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer

✍ Scribed by Allan J. Pantuck; Arie S. Belldegrun

Book ID
107554577
Publisher
Springer
Year
2001
Tongue
English
Weight
37 KB
Volume
2
Category
Article
ISSN
1527-2737

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gene therapy for pain: Results of a phas
Gene therapy for pain: Results of a phase I clinical trial
✍ David J. Fink; James Wechuck; Marina Mata; Joseph C. Glorioso; James Goss; David 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

## Abstract ## Objective: Preclinical evidence indicates that gene transfer to the dorsal root ganglion using replication‐defective herpes simplex virus (HSV)‐based vectors can reduce pain‐related behavior in animal models of pain. This clinical trial was carried out to assess the safety and explo

Allogeneic retrovirally transduced, IL-2
Allogeneic retrovirally transduced, IL-2- and IFN-γ-secreting cancer cell vaccine in patients with hormone refractory prostate cancer—a phase I clinical trial
✍ T. H. Brill; H. R. Kübler; H. v. Randenborgh; F. Fend; H. Pohla; J. Breul; R. Ha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 856 KB

## Abstract ## Background The purpose of this vaccine study was to determine the safety and feasibility of vaccination with an allogeneic prostate carcinoma cell line, LNCaP, expressing recombinant interleukin‐2 (IL‐2) and interferon‐γ (IFN‐γ) and to evaluate the efficacy of inducing tumor‐specifi